Lv4
650 积分 2021-12-21 加入
Zonated mechanosensing by PIEZO1 controls liver regeneration
3个月前
已完结
Mitochondrial control of fuel switching via carnitine biosynthesis
7个月前
已完结
Non-alcoholic fatty liver disease
11个月前
已完结
YAP/TAZ as master regulators in liver regeneration and disease: insights into mechanisms and therapeutic targets
11个月前
已完结
Nonalcoholic fatty liver disease: lifestyle and quality of life
11个月前
已完结
Imbalance in ALR ubiquitination accelerates the progression of nonalcoholic steatohepatitis to hepatocellular carcinoma
11个月前
已完结
Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease
11个月前
已完结
Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
11个月前
已完结
Resmetirom, the first approved drug for the management of metabolic dysfunction-associated steatohepatitis: Trials, opportunities, and challenges
1年前
已完结
Resmetirom: The First FDA-Approved Drug for Metabolic Dysfunction-Associated Steatohepatitis (MASH) with a Perspective on Precision Medicine
1年前
已完结
皖公网安备34019202002308
